Evidence map›Paper›PMID 41006281›Full record

ArticleScientific reports2025

NextGen lung disease diagnosis with explainable artificial intelligence.

Nirmala Veeramani, Reshma Sherine S A, Sakthi Prabha S, Srinidhi S, Premaladha Jayaraman

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. [Advances in Radiomics for Immune Checkpoint Inhibitor-related Pneumonitis 
of Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nirmala VeeramaniSchool of Computing, SASTRA Deemed University, Thirumalaisamudram, 613401, Thanjavur, Tamilnadu, India. nirmalaveeramani@ict.sastra.ac.in.
Reshma Sherine S ASchool of Computing, SASTRA Deemed University, Thirumalaisamudram, 613401, Thanjavur, Tamilnadu, India.
Sakthi Prabha SSchool of Computing, SASTRA Deemed University, Thirumalaisamudram, 613401, Thanjavur, Tamilnadu, India.
Srinidhi SSchool of Computing, SASTRA Deemed University, Thirumalaisamudram, 613401, Thanjavur, Tamilnadu, India.
Premaladha JayaramanSchool of Computing, SASTRA Deemed University, Thirumalaisamudram, 613401, Thanjavur, Tamilnadu, India. premaladha@ict.sastra.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has been the most catastrophic global health emergency of the [Formula: see text] century, resulting in hundreds of millions of reported cases and five million deaths. Chest X-ray (CXR) images are highly valuable for early detection of lung diseases in monitoring and investigating pulmonary disorders such as COVID-19, pneumonia, and tuberculosis. These CXR images offer crucial features about the lung's health condition and can assist in making accurate diagnoses. Manual interpretation of CXR images is challenging even for expert radiologists due to the overlapping radiological features. Therefore, Artificial Intelligence (AI) based image processing took over the charge in healthcare. But still it is uncertain to trust the prediction results by an AI model. However, this can be resolved by implementing explainable artificial intelligence (XAI) tools that transform a black-box AI into a glass-box model. In this research article, we have proposed a novel XAI-TRANS model with inception based transfer learning addressing the challenge of overlapping features in multiclass classification of CXR images. Also, we proposed an improved U-Net Lung segmentation dedicated to obtaining the radiological features for classification. The proposed approach achieved a maximum precision of 98% and accuracy of 97% in multiclass lung disease classification. By leveraging XAI techniques with the evident improvement of 4.75%, specifically LIME and Grad-CAM, to provide detailed and accurate explanations for the model's prediction.

Indexed as

Artificial IntelligenceCOVID-19Lung DiseasesHumansLungRadiographic Image Interpretation, Computer-AssistedRadiography, ThoracicSARS-CoV-2Early disease detectionExplainable artificial intelligenceLIME and Grad-CAMLung disease detectionSegmentationTransfer learning

Identifiers

PMID41006281
PMCPMC12475433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.